These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Pimecrolimus in dermatology: atopic dermatitis and beyond. Gisondi P; Ellis CN; Girolomoni G Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622 [TBL] [Abstract][Full Text] [Related]
31. Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study. Ma Y; Lu Z J Dermatolog Treat; 2010 May; 21(3):171-7. PubMed ID: 20394493 [TBL] [Abstract][Full Text] [Related]
32. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL; Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204 [TBL] [Abstract][Full Text] [Related]
33. The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis. Caproni M; Torchia D; Antiga E; Volpi W; del Bianco E; Fabbri P J Clin Immunol; 2006 Jul; 26(4):370-5. PubMed ID: 16773453 [TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. Wollenberg A; Sidhu MK; Odeyemi I; Dorsch B; Koehne-Volland R; Schaff M; Ehlken B; Berger K Br J Dermatol; 2008 Dec; 159(6):1322-30. PubMed ID: 18782316 [TBL] [Abstract][Full Text] [Related]
35. Differential expression of cell adhesion molecules in inflamed appendix: correlation with clinical stage. Bittinger F; Brochhausen C; Köhler H; Lehr HA; Otto M; Skarke C; Walgenbach S; Kirkpatrick CJ J Pathol; 1998 Dec; 186(4):422-8. PubMed ID: 10209493 [TBL] [Abstract][Full Text] [Related]
36. Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions. Simon D; Lindberg RL; Kozlowski E; Braathen LR; Simon HU Exp Dermatol; 2006 Jun; 15(6):441-6. PubMed ID: 16689860 [TBL] [Abstract][Full Text] [Related]
37. Topical treatment for atopic dermatitis in the 21st century. Johnson SM; Kincannon JM; Dudney DL; J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500 [TBL] [Abstract][Full Text] [Related]
38. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. Koo JY; Fleischer AB; Abramovits W; Pariser DM; McCall CO; Horn TD; Gottlieb AB; Jaracz E; Rico MJ J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175 [TBL] [Abstract][Full Text] [Related]
39. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects. Rico MJ; Lawrence I Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507 [TBL] [Abstract][Full Text] [Related]
40. The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions. Grzanka A; Zebracka-Gala J; Rachowska R; Bozek A; Kowalska M; Jarzab J Exp Dermatol; 2012 Mar; 21(3):184-8. PubMed ID: 22142393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]